ClinicalTrials HQ

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Recruiting · NCT06805305 · Registry updated 2026-07-01
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumorRecruitingPhase 22026-07-01NCT06805305

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Diakonos Oncology Corporation3

18 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atlantic HealthSummitUnited States3
Banner Md Anderson Cancer CenterGilbertUnited States121
Baptist MD Anderson Cancer CenterJacksonvilleUnited States72
Baylor College of MedicineHoustonUnited States1
City of HopeDuarteUnited States238
Cooper University Health CareCamdenUnited States11
Dana-Farber Cancer InstituteBostonUnited States68
HoagNewport BeachUnited States5
Lenox Hill HospitalNew YorkUnited States87
Rutgers Cancer InstituteNew BrunswickUnited States41
The Ohio State University Comprehensive Cancer CenterColumbusUnited States29
The University of Texas Health Science Center at San AntonioSan AntonioUnited States26
UCSFSan FranciscoUnited States27
UNC Lineberger Comprehensive Cancer CenterChapel HillUnited States243
UPMC Presbyterian HospitalPittsburghUnited States22
UTHealth HoustonHoustonUnited States17
Vanderbilt-Ingram Cancer CenterNashvilleUnited States9
Wake Forest University Health SciencesWinston-SalemUnited States330